STOXX has acquired Scientific Beta, a specialist in smart factor and ESG/Climate index design, for an undisclosed amount. Scientific Beta, which was a wholly owned subsidiary of SGX Group, brings a strong academic heritage and a focus on scientific rigor to its index solutions. Established in 2012 by the EDHEC-Risk Institute, Scientific Beta has pioneered advances in factor and ESG/Climate index methodologies, aiming to encourage their adoption across the investment industry. SGX Group had initially acquired a majority stake in 2020, completing full ownership in 2025, and maintained Scientific Beta's principles of independent, empirical-based academic research.
This acquisition strategically enhances STOXX's capabilities as a global index provider. STOXX aims to integrate Scientific Beta's advanced research and sophisticated index construction methodologies into its existing offerings. Scientific Beta's expertise in smart factor and ESG/Climate solutions, developed with full transparency and scientific validation, complements STOXX's commitment to delivering robust and innovative index products to its clients worldwide. The move is expected to strengthen STOXX's position in the rapidly evolving market for factor-based and sustainable investment solutions.
The combination of STOXX's extensive global distribution network and market presence with Scientific Beta's deep academic research and specialized index design capabilities is anticipated to create significant synergies. Clients are expected to benefit from a broader and more sophisticated suite of index solutions, combining rigorous scientific backing with scalable implementation. This integration will allow for accelerated development and wider accessibility of cutting-edge investment tools, particularly in areas of smart beta and sustainable investing.
Looking ahead, the combined entity is poised to drive further innovation in the index industry. By leveraging Scientific Beta's research-driven approach and STOXX's operational scale, the acquisition aims to deliver enhanced value to institutional investors seeking advanced, transparent, and scientifically proven index strategies for their portfolios.